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Abstract
Genetic individuality is the foundation of personalized medicine, yet its determinants are currently poorly understood. One
issue is the difference between monozygotic twins that are assumed identical and have been extensively used in genetic
studies for decades [1]. Here, we report genome-wide alterations in two nuclear families each with a pair of monozygotic
twins discordant for schizophrenia evaluated by the Affymetrix 6.0 human SNP array. The data analysis includes
characterization of copy number variations (CNVs) and single nucleotide polymorphism (SNPs). The results have identified
genomic differences between twin pairs and a set of new provisional schizophrenia genes. Samples were found to have
between 35 and 65 CNVs per individual. The majority of CNVs (,80%) represented gains. In addition, ,10% of the CNVs
were de novo (not present in parents), of these, 30% arose during parental meiosis and 70% arose during developmental
mitosis. We also observed SNPs in the twins that were absent from both parents. These constituted 0.12% of all SNPs seen in
the twins. In 65% of cases these SNPs arose during meiosis compared to 35% during mitosis. The developmental mitotic
origin of most CNVs that may lead to MZ twin discordance may also cause tissue differences within individuals during a
single pregnancy and generate a high frequency of mosaics in the population. The results argue for enduring genome-wide
changes during cellular transmission, often ignored in most genetic analyses.
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Introduction
Genome-wide constancy and change underlies evolution and
familial inheritance but remains ill-defined. An assessment of
changes as the genome is passed on from one generation (meiosis)
and developmental cycle (mitosis) to the next is needed. It directly
contributes to the sum of genetic individuality. At present, these
inquiries are difficult [2], and require the development of new
quantitative methods to assess genome-wide changes and their
significance. This report assesses two common measures of
genomic variation: copy number variations and (CNVs) and single
nucleotide polymorphism (SNPs) across a generation and between
monozygotic twins in two exceptional families. The results offer
novel insight into meiotic and mitotic sources of variation, which
results in genetic individuality between MZ twins. This individ-
uality may account for discordance in monozygotic twins for a
variety of diseases including schizophrenia.
CNVs are structural variants that are both frequent and
relevant and may range in size in humans from 1 Kb to several
Mb [3]. Given their impact on physiology and function, CNVs
have a major influence on evolution and gene expression and on
normal and disease related variation [3]. CNVs include duplica-
tions and deletions leading to a departure from the classic view
that all autosomal genes are present in two copies, with one allele
inherited from each parent. The majority of CNVs are copy
number polymorphisms (CNPs), existing in a frequency that is
greater than 1% and transmitted across generations. However, a
small proportion of CNVs are novel events. CNVs may account
for a major fraction (,12%) of the genome, but appear to
concentrate in some genomic regions depending on the sequence
features [4,5]. Unlike CNVs, SNPs are relatively small changes,
usually involving replacement of a nucleotide with another. SNPs
are common and distributed across the entire human genome.
Individual SNPs mark a unique genomic location, and are usually
neutral in nature. In other cases, they may change amino-acids,
cause protein truncation or affect expression. They are easily
detected, and have been extensively exploited in genetic analysis
including the cloning of disease causing genes, individual
identification and establishment of genetic relatedness.
Studies on these two genome-wide variations (SNPs and CNVs)
have greatly enhanced our understanding of evolution and genetic
individuality. They arealso helping to elucidatethecause ofgenetic,
and genomic disorders including schizophrenia [6]. A number of
SNPs appear to be linked to this complex neuro-developmental
disease, which has a heritability estimate of 80%. However, results
of linkage studies have not been consistently reproducible [7,8].
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elevated incidence of CNVs [9] and a few rare CNVs appear to
have a major effect on the development of SCZ [10]. However,
these CNVs account for only a small fraction of schizophrenia cases
[11] and the challenge of identifying common genetic cause(s) of
SCZ remains. The search for genes in SCZ currently relies on large
number of patients and matched controls. The limited progress
using these approaches emphasizes the need to pursue alternative
approaches. Future studies may benefit from inclusion of two
features. The first is a genome-wide comparison of the parents and
their progeny affected by SCZ and the second is the assessment of
genomes of monozygotic twins (that show ,52% discordance for
SCZ) [12,13]. The current study reports genome-wide CNV and
SNP results on two exceptional families that include monozygotic
twins discordant for schizophrenia (Figure 1, Table 1).
Results and Discussion
Familial Distribution of CNVs
The number of CNVs per individual ranged from 35 to 65, with
the exception of one individual who is described more fully later
(Table 2). This is similar to the number of CNVs per subject
reported from most other studies that have used Affymetrix 6.0
Human SNP arrays [14]. The range is also comparable with the
number of CNVs found in Venter’s genome (62) based on his
complete genome sequence [15]. The exception in our study was
the father in family 2 (II-1-1) who was found to harbour a rare
chromosome 13q deletion containing 40 CNVs at a single
genomic location. Although this finding is beyond the scope of
this report, it is important to note that II-1-1 underwent
chemotherapy treatment and that the samples utilized in this
study were obtained towards the end of that treatment. Most
CNVs identified were in the range of 100 to 200 Kb, consistent
with the size distribution of CNVs reported in the literature [14].
The majority of CNVs observed (Table 3) were copy number gains
(78.5%) and ,10% of the CNVs identified are not listed in the
Database of Genomic Variants (http://projects.tcag.ca/variation/
) accessed on 8.2.2010. Further, the chromosomal distribution of
CNVs was comparable across individuals with the exception of the
father in family 2 who had consistently higher CNVs affecting
most chromosomes (Table 4). Of the CNVs identified, .50 per
cent overlapped RefSeq genes. The identified genes are frequently
associated with metabolic pathways such as starch and sucrose
metabolism as well as pathways involved in the metabolism of
amino acids, for example, , phenylalanine, histidine and tyrosine
(AMY2A,AMY1A,ALDH1L1,PSMC1). Structurally, .67% of the
CNVs identified were flanked at both the 59and 39 end or at just
the 59 (.7%) or 39 (.8%) end with a set of common repeats,
represented by short interspersed nucleotide elements (SINEs),
long interspersed nucleotide elements (LINEs), long terminal
repeats (LTRs) and low copy repeats (LCRs) near the breakpoints.
The majority of the deletion breakpoints had 1–30 bp of
microhomology, whereas a small fraction of deletion breakpoints
contained inserted sequences. The co-occurrence of microhomol-
ogy and inserted sequence suggests that both recombination and
replication based mutational mechanisms are operational in CNV
generation. Recent studies have identified short DNA motifs that
both determine the location of meiotic crossover hotspots and are
significantly enriched at the breakpoints of recurrent non-allelic
homologous recombination (NAHR) syndromes [16]. We found
evidence for this mechanism in a subset of the breakpoint events
(data not shown). This was true for the de novo (Figure 2a) as well as
inherited (Figure 2b) CNVs. Such sequences may represent
genomic architecture that is prone to genome instability by a
predisposition to genomic rearrangements via non-homologous
end joining (NHEJ), template switching and/or non-allelic
homologous recombination (NAHR).
Familial vs de novo Origin of CNVs
A novel feature of the data included in this report is that we are
able to classify observed CNVs into two groups based on their
Figure 1. Pedigree of two families with monozygotic twins
discordant for schizophrenia. Members of the family one are
indicated with (I-) and members of the family two are indicated with (II-
). The designations included in this figure are followed in subsequent
figures and tables.
doi:10.1371/journal.pone.0017125.g001
Table 1. Demography and Clinical History.
Family 1 Family 2
I-1-1 I-1-2 I-2-1 I-2-2 II-1-1 II-1-2 II-2-1 II-2-2
Age (yr.) at
assessment
82 74 53 53 N/A N/A 43 43
Sex Male Female Female Female Male Female Female Female
Declared Race Afro-American Caucasian
Psychiatric
features
Compulsive
Personality
Disorder
N/A Schizophrenia,
Paranoid Type,
onset age 22
Bipolar I
Disorder,
onset age 52
Major depression and panic
disorder for 6 months after
cardiac surgery, onset age 73
N/A Schizoaffective
Disorder, onset age
27
Single episode of Major
Depression, fully
remitted, onset age 18
Demography and Clinical History of monozygotic (MZ) twins discordant for Schizophrenia (SCZ). Family one is indicated with (I), family two is indicated with (II).
N/A=Not Applicable.
doi:10.1371/journal.pone.0017125.t001
Sources of Genomic Discordance between MZ Twins
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in one or both twins and not seen in either parent, were classified
as de novo.I fade novo CNV was present in both twins, it was
considered to have originated during parental meiosis and when
present in only one of the two twins, it was assumed to have
originated in mitosis during development. This classification
allowed us to identify 14 and 26 de novo CNVs in family 1
(Table 5) and family 2 (Table 6) respectively. The table includes
genomic locations as well as individual specific break points which
allow for the assessment of regions of overlap with the Database of
Genomic Variants (Toronto, Ontario). Mitotic origin of CNVs
was ,3 times higher than CNVs generated during parental
meiosis. Of the mitotic de novo CNVs identified two (loss at
14q32.11 as well as loss at 8q11.21) were specific to the
schizophrenia patient in family 1 and one (gain at 19q13.41) was
specific to the patient in family 2. Such results are novel in the
literature. Further, it is enticing to ask the question, do the genes
disturbed by CNVs contribute to the development of their disease
symptoms? Although the answers to such questions are of
paramount importance, the results available do not offer a direct
assessment of such questions. Nonetheless, it is appropriate to
entertain the discussion that the known features of these genes are
or are not compatible with disturbances observed in schizophre-
nia, which is discussed below.
De novo CNVs and Schizophrenia
The genes overlapping disease specific de novo CNVs in family 1
included PSMC1 (proteasome 26S subunit, ATPase, 1) and
C14orf102 (chromosome 14 open reading frame 102 gene) on
14q32.11 and KIAA0146 on 8q11.21. PSMC1 (MIM 602706) is an
ATP-dependent protease [17] that may include protein ubiquiti-
nation in response to DNA damage [18]. It is composed of a 20S
catalytic proteasome and 2 PA700 regulatory modules and
contains an AAA (ATPases associated with diverse cellular
activities) domain [17]. The human and mouse proteins are
99% identical [19] and may play a significant role in ubiquitin-
mediated proteasomal proteolysis in the molecular pathogenesis of
neurological diseases such as spinocerebellar ataxia type 7 (SCA7).
Also, several studies (for review, see [20,21]), have indicated that
the genes related to ubiquitination are altered in the brains of
patients with schizophrenia. Further, this CNV also affects another
gene (C14orf102; chromosome 14 open reading frame 102) which
is conserved across phyla and highly expressed in the brain
Table 2. Distribution of CNV among family members
according to size.
CNV Size Family 1 Family 2
I-1-1 I-1-2 I-2-1 I-2-2 II-1-1 II-1-2 II-2-1 II-2-2
,=100 kb 00002 0 0 1
.100 to 200 kb 17 18 15 20 119 50 24 24
.200 to 300 kb 1 1 641 0 2 56 1 39
.300 to 400 kb 55651 13 1 4
.400 to 500 kb 20226 1 1 2
.500 to 1000 kb 62477 2 5 2
.1t o1 0M b 94535 2 4 5
.10 to 20 Mb 50000 0 0 0
.20 Mb 30002 0 2 2
Total 58 35 36 47 177 64 50 49
Numerical values in each cell of the table indicate how many CNVs of that
particular size range were observed in that particular individual.
doi:10.1371/journal.pone.0017125.t002
Table 3. Identity of copy number variants across individual
family members.
CNVs Family 1 Family 2
I-1-1 I-1-2 I-2-1 I-2-2 II-1-1 II-1-2 II-2-1 II-2-2
No. of Loss 2 1 6565 2 1 1 64
No. of Gain 37 29 31 41 125 53 44 45
Novel (absent in
DGV)
11024 2 610
Present in DGV 57 34 36 45 135 58 49 49
Total (for the
individual)
58 35 36 47 177 64 50 49
Frequency of CNVs which are losses (deletion) or gains (duplication) and
characterization as present or absent from The Database of Genomic Variants
(DGV).
doi:10.1371/journal.pone.0017125.t003
Table 4. Chromosome wise distribution of CNV.
Chr No. Family 1 Family 2
I-1-1 I-1-2 I-2-1 I-2-2 II-1-1 II-1-2 II-2-1 II-2-2
1 42221 12 6 6
2 42551 12 2 3
3 14237 4 4 2
4 43248 1 3 2
5 00001 20 2 1
6 00001 02 0 0
7 26341 05 3 4
8 10337 3 3 3
9 11234 4 3 4
10 21113 5 1 1
11 31215 1 2 2
12 01014 3 0 1
13 00004 01 1 0
14 46354 6 5 3
15 43132 6 6 8
16 21239 1 1 1
17 41238 2 2 1
18 00001 0 0 1
19 01007 3 2 1
20 00000 0 0 1
21 12232 3 2 1
22 30323 1 1 1
X 1 8 0119 9 1 2
Total 58 35 36 47 177 64 50 49
Chromosome specific distribution of de novo (present in twin(s) and not in
parents) and inherited (present in at least one parent) CNVs in family 1 and
family 2.
Chr. No=Chromosome number.
doi:10.1371/journal.pone.0017125.t004
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PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e17125(Affymetrix GNF Expression Atlas 2 Data). The other CNV
affected in this patient of family 1 represents a loss at 8q11.21, that
contains the still uncharacterized gene, KIAA0146, which is
expressed in the brain, may contain a CAG repeat and is
conserved in chimpanzee, dog, cow, mouse, rat, chicken, and
zebra fish. It is a transcription factor with CCAAT enhancer
binding protein (CEBP) function [22]. Further the gene is highly
expressed in the brain and hippocampus that may implicate it in
mental disorders (www.genecards.org). Although we cannot rule
out a role for these three genes (PSMC1, C14orf102 and KIAA0146)
in schizophrenia, such conclusions would be premature. Only a
follow up study will establish if any of the three genes directly
contribute to the development of schizophrenia in the patient from
family 1. A similar analysis of CNVs in family 2 has identified a
109 kb gain at 19q13.41 that is specific to the schizophrenia
patient in family 2. Translocations involving 19q13 are a frequent
finding in follicular adenomas of the thyroid and may represent
the most frequent type of structural aberration in human epithelial
tumors [23]. The CNV identified in this region contains two
genes; DPRX1 and ZNF331. DPRX1 (divergent-paired related
homeobox) is a member of the DPRX homeobox gene family,
contains a single conserved homeodomain and may function as a
putative transcription factor. It may bind a promoter or enhancer
sequence or interact with a DNA binding transcription factor and
is involved in early embryonic development and cell differentiation
[24]. The drosophila homologue of the DPRX1 gene (dPrx5;
Figure 2. Distribution of repeat elements 1 kb upstream (59) and 1 kb downstream (39) of the de novo (2a) and inherited (2b) CNVs
across eight individuals. These include LINE (blue), SINE (purple), LTR (yellow), Satellite (sky blue), simple repeats (black) and low complexity
repeats (green) with numerical values on top of the bars representing percentage of that repeat.
doi:10.1371/journal.pone.0017125.g002
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PLoS ONE | www.plosone.org 8 March 2011 | Volume 6 | Issue 3 | e17125Drosophila peroxiredoxin 5) confers protection against oxidative
stress, apoptosis and also promotes longevity [25]. The next gene,
ZNF331(zinc finger protein 331) affected by this CNV is also
involved in DNA-dependent regulation of transcription as a
transcriptional repressor [26]. Interestingly, it is one of the
imprinted genes that exhibits monoallelic expression in a parent-
of-origin specific manner [27]. Imprinted genes are important for
development and behaviour and disruption of their expression is
associated with many human disorders [28]. In conclusion the
three genes affected in the schizophrenia patient in family 1
(PSMC1, C14orf102, KIAA0146) and the two genes affected in the
patient of family 2 (DPRX1 and ZNF331) could not be excluded
from their potential involvement in the development of schizo-
phrenia in the two patients. If applicable, the biological systems
affected in the two patients is hypothesized to be different. The
patient in family one is hypothesized to have a ubiquitin-mediated
proteasomal proteolysis while the patient of family 2 could have
errors in regulatory mechanisms affecting gene regulation. Such
conclusions must remain hypothetical until proven by independent
supporting evidence.
De novo changes may lead to mosaicism
The genotypes generated by the Affymetrix 6.0 array have also
allowed us to establish that ,0.12% (1086 and 1022 in twin pair 1
and 2 respectively; 11 substitutions shared by both pairs) of the
SNPs in the twins represented de novo substitutions, but unlike
CNVs, (that primarily originated during ontogeny in mitosis) most
(63–65%) originated during parental meiosis. These results suggest
that DNA replication fidelity at the level of single base pairs (SNPs)
vs replication forks (CNVs) is differentially exercised during
meiosis and mitosis. The single base pairing is much more
stringent in mitosis (evolved to produce identical daughter cells),
compared to meiosis where errors can facilitate potentially
beneficial variations. In contrast, CNVs which affect the
phenotype may be advantageous when occurring during mitosis
and selected for during development. Thus, cell type specific
CNVs may play a role in growth and development, offering
advantageous variability. This would mean that most individuals
are mosaics [29]: a hypothesis that is difficult to assess and
evaluate. It is likely that the ratio of mosaic cells may be
maintained throughout the differentiated (ectoderm, mesoderm,
endoderm, etc) tissues over the lifetime [30,31]; an exception being
when other factors are directly influencing DNA stability. Such a
mechanism may generate genomic differences and differential
mosaicism in most or all individuals. If this is the case, it will
complicate traditional genetic analysis that assumes stability of the
genome with rare exceptions.
We have been able to establish genome-wide (CNVs and SNPs)
discordance for MZ twin pairs. Also, given that the twins are
discordant for schizophrenia, it is possible to assign provisional
CNVs (and genes) as well as substitutions (SNPs) that may be
associated with the disease status of the affected twins in family 1
and family 2 (Table 7,8). Similarly, we identified substitutions
(SNPs) that were different between the affected and unaffected
member of the two sets of twins including their distribution along
the chromosomes, introns and exons and the predicted effect on
the gene product. Identity of de novo CNVs found in Family 1
(Table 5) and Family 2 (Table 6) and the gene regions which they
overlap was reported. De novo CNVs are defined as those that are
present in either twin but not found in parents. In the tables, SD
indicates the percentage of overlap between segmental duplica-
tions and the CNVs, ‘0’ means there is no overlap between CNV
and segmental duplication and ‘1’ means 90–100% overlap.
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PLoS ONE | www.plosone.org 11 March 2011 | Volume 6 | Issue 3 | e17125We also analyzed genes that overlapped de novo CNVs (gains and
losses) in order to assess their potential effect on physiology and
function starting with GO ontology annotation (http://www.
geneontology.org). Interestingly, the majority of genes belonged to
transcription, DNA replication, transport, and cell signalling
pathways, including ‘binding’ or ‘catalytic’ functions. A number
of these genes are expressed in the brain, some with potential to
affect neurophysiology, neurodevelopment and function and a set
of them are known to show altered expression in schizophrenia
(www.schizophreniaforum.org). Also of significance is the obser-
vation that the FAM19A5 protein encoded by the FAM19A5 gene
(22q13.32) belongs to the TAFA protein family which are
predominantly expressed in the brain, and are postulated to
function as brain-specific chemokines or neurokines, that act as
regulators of immune and nervous cells [32]. This finding adds to
the existing speculation about the role of the Major Histocompat-
ability Loci (MHC) and infection in SCZ. Functional analysis of
this gene and upstream regulatory elements for characteristic
patterns of nucleosome occupancy changes associated with
enhancers could yield novel insights into the role of this gene in
psychiatric disorders. IPA analysis of gene networks of CNVs and
SNPs converged on cell cycle, cellular growth and proliferation.
Genes involved in genetic disorders such as hematological disease,
immunological, inflammatory and developmental disorders were
overrepresented. These results support the hypothesis that
schizophrenia is a ‘‘developmental disorder’’ at the molecular
level. Interestingly, a recent co-expression network analysis of
microarray-based brain gene expression data revealed perturba-
tions in developmental processes in schizophrenia [33]. However,
given that these results are based on only two twin pairs, and
schizophrenia is highly heterogeneous, the results on disease
causations cannot be generalized. Also, we have offered other
explanations for twin discordance that may involve epigenetic
changes [34].
It is not surprising that genomic studies have begun to use
monozygotic twins. In fact a number of them have identified copy
number variations [35] and epigenetic [36–38] differences
between them; an exception to these results is a recent study by
Baranzini et al [39]. They studied three pairs of monozygotic twins
discordant for Multiple Sclerosis (MS) and found no difference
that could account for the disease causation. The results may be
viewed as not surprising for a number of reasons. First, MS is
known to have significant environmental components including
sunlight and viruses, among others, [40] and the concordance rate
in monozygotic twins is only ,30%. Second, they assessed the
CD4+ lymphocytes only that may or may not represent the
causative cell type. Also, they sequenced the genome of CD4+ cells
from a single pair corresponding to 21.7 and 22.5-fold coverage
representing 99.6% and 99.5% of the NCBI human reference
genome, which may or may not be effective. Only additional
genomic and epigenomic studies on MZ twins will offer insights
into the dynamics of genomic stability and change, that forms the
focus of this report.
In summary, the present study adds to the recent effort in
human genetics to define the phenomenon of constancy and
change using inheritance and origin of genome-wide CNVs and
SNPs. The results demonstrate that CNVs often result from
mitosis during early development facilitated by flanking repeats.
They may lead to CNV differences among different tissue and
make most individuals mosaics. The described approach expands
the search for disease related genetic changes, indicates the time of
their occurrence and begins to interrogate the mechanisms
involved.
Materials and Methods
This research was approved by the Committee on Research
Involving Human Subjects at the University of Western Ontario.
The families and patients were identified, recruited and clinically
assessed by Dr. Richard O’Reilly (Psychiatrist) and all participants
(Figure 1) gave informed consent and provided blood and buccal
cells for this research. All subjects were interviewed using the
Structured Clinical Interview for DSM IV and the SCID II (for
personality disorders) and their medical records collected and
reviewed. Diagnoses and demographic information are listed in
Table 1. DNA was extracted from the collected white blood cells
using the perfect pure DNA blood kit (5prime.com) following the
manufacturer’s protocol. Subsequent microarray analysis was
performed using the Affymetrix Genome-Wide Human SNP
Array 6.0 at the London Regional Genomics Centre (LRGC)
following manufacturer’s protocol and stringent quality control
measures. Briefly, 5 mg of genomic DNA was labelled and
hybridized to Affymetrix SNP 6.0 arrays. CNVs called by both
Affymetrix Genotyping Console 4.0 and PartekH Genotyping
Suite
TM software suites were retained for analysis. In both cases,
the CNVs were identified by continuity of markers on a segment.
Two CNVs that overlapped by .50% in the two methods of data
analysis were given the same identity. Every measure was
undertaken to avoid inclusion of false positives including
correction for segmental duplications. We found evidence of
CNVs associated with segmental duplications which agrees with
previous studies [41]. The CNVs identified were further assessed
by comparison to the Database of Genomic Variants (http://
projects.tcag.ca/variation/) and annotated with gene symbols by
importing the annotation file from the UCSC genome browser
(NCBI36/hg 18). A CNV that was present in both members of the
twin pair and not in either of their two parents was considered to
be meiotic de novo (originated during gamete formation), while a
CNV that was present in one of the two twins and not present in
either parent was considered to be mitotic de novo (originated
during development). Further, a CNV present in the SCZ affected
twin only (as compared to the two parents and unaffected member
of the pair or the database) was classified as ‘‘provisional de novo
CNV’’ for this disease. Novel CNVs discovered in this study were
validated for predicted CNVs by Real Time PCR analysis with an
internal control (RNAseP gene) using TaqMan detection chem-
istry and the ABI Prism 7300 Sequence Detection System (Applied
Biosystems, http://www.appliedbiosystems.org). The copy num-
ber of the test locus in each case was defined as 2T
2DDC where
DCT is the difference in threshold cycle number for the test and
reference loci.
Additional CNV analysis focused on two aspects. The first deals
with identification of putative repeat elements in the flanking
regions of CNVs; within a 1 kb region upstream and downstream
of the CNV breakpoint which could promote breakage, deletion
and duplication. The identification of repeat elements was carried
out using repeat masker (http://www.repeatmasker.org/). Sec-
ondly, a probable mechanism associated with sequence-specific
susceptibility to CNVs was queried. This data was used to test
models related to the origin of CNVs. Previously reported
candidates for CNV mechanisms include Non-Allelic Homologous
Recombination (NAHR), Non-Homologous End Joining (NHEJ),
Fork Stalling and Template Switching (FoSTeS) and Microho-
mology-Mediated Break-Induced Replication (MMBIR) [42]. The
second line of investigation involved functional characterization of
genes by matching of the identified genes with the Schizophrenia
Gene Database (http://www.schizophreniaforum.org/res/
sczgene/default.asp) as well as their assessment by GO ontology
Sources of Genomic Discordance between MZ Twins
PLoS ONE | www.plosone.org 12 March 2011 | Volume 6 | Issue 3 | e17125(http://www.geneontology.org/). The genes identified were also
subjected to IPA analysis (www.ingenuity.com) that identified the
nature of gene interactions and the pathways involved.
The use of Affymetrix 6.0 Human SNP array also allowed us to
assess the transmission of a total of 909622 SNPs that are
contained on the array. It allowed us to identify SNPs in the twins
that were not present in either of the two parents; considered to be
de novo. The origin of the de novo SNPs was assumed to be parental
meiosis if both twins carried the novel nucleotide. In contrast, the
origin of the de novo SNPs was assumed to be somatic development
(mitosis) if only one of the two twins carried the novel nucleotide.
We were able to assign novel substitutions to different categories
including their potential effect on the gene and gene product, as
well as pathways that may be affected.
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